Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis.

Basavaraju, Rakshathi; Guo, Jia; Small, Scott A; Lieberman, Jeffrey A; Girgis, Ragy R; Provenzano, Frank A

Basavaraju, Rakshathi; Guo, Jia; Small, Scott A; Lieberman, Jeffrey A; Girgis, Ragy R; Provenzano, Frank A.

Affiliation

Basavaraju R; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University Medical Center, New York, New York.
Guo J; New York State Psychiatric Institute, Department of Psychiatry, Columbia University Medical Center, New York.
Small SA; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University Medical Center, New York, New York.
Lieberman JA; New York State Psychiatric Institute, Department of Psychiatry, Columbia University Medical Center, New York.
Girgis RR; New York State Psychiatric Institute, Department of Psychiatry, Columbia University Medical Center, New York.
Provenzano FA; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University Medical Center, New York, New York.

JAMA Psychiatry ; 79(2): 178-179, 2022 02 01.

Article de En | MEDLINE | ID: mdl-34964821

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Troubles psychotiques / Acide glutamique / Hippocampe Type d'étude: Diagnostic_studies / Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limites: Adolescent / Adult / Female / Humans / Male Langue: En Journal: JAMA Psychiatry Année: 2022 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google